Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# IMVACS

## Sitemaps

- [XML Sitemap](https://www.imvacs.org/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [IMVACS Annual Meeting Y2](https://www.imvacs.org/imvacs-annual-meeting-y2/) - The IMVACS Consortium held its Year 2 Annual Meeting on 22nd–23rd April 2026 at the Hilton Garden Inn in Lecce, Italy, in a hybrid format. It was a great opportunity to review progress, share preliminary results and experiences, and align on next steps across all study sites.
- [IMVACS at MSF Scientific Day 2026](https://www.imvacs.org/imvacs-at-msf-scientific-day-2026/) - We’re proud to share that some partners from the IMVACS consortium will take part in the upcoming MSF Scientific Day on 20th May in London.
- [SAFLI-R21-10](https://www.imvacs.org/safli-r21-10/) - SAFLI-R21-10 is an ancillary study conducted within the framework of the IMVACS project and designed to compare the safety, reactogenicity, and humoral immunogenicity of the 10-dose formulation of R-21/Matrix-M with 2-Phenoxyethanol preservative vs the safety, reactogenicity, and humoral immunogenicity of the 2-dose formulation of R21/Matrix-M vaccine.
- [IMVACS at ASTMH 2025](https://www.imvacs.org/imvacs-at-astmh-2025/) - Some members of our IMVACS team proudly attended the ASTMH 2025 Annual Meeting (9-13th November, Toronto), one of the leading international conferences in global health.
- [CoSAV-R21](https://www.imvacs.org/cosav-r21/) - Epicentre/Médecins Sans Frontières, in collaboration with other IMVACS partners, is conducting the CoSAV-R21 trial in southern Chad to identify the most effective delivery strategy for the R21/Matrix-M™ malaria vaccine for children under five in areas with high seasonal malaria transmission. 👉 Watch the video to learn more:https://youtu.be/l-yCwbBU4jI?si=lwQmxET1NO7_TNU9
- [IMVACS Project – First Round of Cross-Sectional Survey ](https://www.imvacs.org/imvacs-project-first-round-of-cross-sectional-survey/) - The first survey was conducted in Mali (20th Nov – 6th Dec 2025), involving 824 children (412 in the control arm and 412 in the intervention arm) across 16 clusters. In Burkina Faso (18th Nov – 3rd Dec 2025), the first survey involved 824 children (412 in the control arm and 412 in the intervention
- [Fieldworker training workshop on acceptability, feasibility, and cost-effectiveness in Mali and BF](https://www.imvacs.org/fieldworker-training-workshop-on-acceptability-feasibility-and-cost-effectiveness-in-mali-and-bf/) - Fieldworkers were trained on the qualitative and quantitative components of the IMVACS trial during a workshop held in November 2025 in Bamako (Mali) and Nanoro (Burkina Faso).
- [World Children’s Day – 20th November 2025](https://www.imvacs.org/world-childrens-day-20th-november-2025/) - On 20th November 2025, the IMVACS Consortium celebrates World Children’s Day 🌍 with the release of a short video, renewing its promise, dedication, and commitment to ensuring a brighter, healthier future for children in Mali and Burkina Faso.
- [Echoes from the Field - Chapter IV](https://www.imvacs.org/echoes-from-the-field-chapter-iv/) - 📅 24th October 2025📍 Dioïla District, Mali👥 Participants enrolled in the IMVACS study to date: 28,837 It’s a wrap!For this year, the IMVACS team has successfully completed all four rounds of R-21 vaccine administration — in Mali from October 9th to 13th, and in Burkina Faso from October 16th to 19th.
- [Echoes from the Field – Chapter III](https://www.imvacs.org/echoes-from-the-field-chapter-iii/) - 📅 1st October 2025📍 Dioïla District, Mali👥 Participants enrolled in the IMVACS study to date: 28,096 Back to Mali for the third page of our field diary, where the story continues to unfold.
- [Echoes from the Field - Chapter II](https://www.imvacs.org/echoes-from-the-field-chapter-ii/) - 📅 8th August 2025📍 Boussé District, Burkina Faso👥 Participants enrolled in the IMVACS study to date: 23,774 The IMVACS journey continues: our second diary page straight from the field takes us to Burkina Faso.
- [Echoes from the Field - Chapter I](https://www.imvacs.org/echoes-from-the-field-chapter-i/) - 📅 29th July 2025📍 Kola Cscom, Dioïla District, Mali👥 Participants enrolled in the IMVACS study to date: 23,227 The first diary page that brings to life the daily efforts of our field team and highlights the ongoing journey of the IMVACS trial.
- [Job announcement!](https://www.imvacs.org/job-announcement/) - The Liverpool School of Tropical Medicine (LSTM) is excited to invite applications for two academic positions to support ongoing research on vaccine implementation in Burkina Faso, Mali, and Chad.Successful candidates will join the IMVACS project and contribute to other vaccine-related research initiatives.🔍 Open Positions:1. Lecturer / Senior Lecturer in Health Economics (Vaccines): to contribute to
- [Official start of vaccination in Mali](https://www.imvacs.org/official-start-of-vaccination-in-mali/)
- [Official start of vaccination in Burkina Faso](https://www.imvacs.org/official-start-of-vaccination-in-burkina-faso/)
- [Prof. Halidou Tinto Visits Serum Institute of India to Advance Malaria Vaccine Collaboration ](https://www.imvacs.org/prof-halidou-tinto-visits-serum-institute-of-india-to-advance-malaria-vaccine-collaboration/) - The Serum Institute of India has donated the vaccines enabling the conduct of the IMVACS clinical trial and is also the sponsor of its ancillary study, the SAFLI-R21-10.From June 1–4th, 2025, Professor Halidou Tinto visited the Serum Institute of India in Pune, further strengthening collaboration with this group of researchers.
- [Stakeholders’ Workshop for formative research in Burkina Faso](https://www.imvacs.org/stakeholders-workshop-for-formative-research-in-burkina-faso/)
- [CoSAV-R21 trial](https://www.imvacs.org/cosav-r21-trial/) - On the 18th anniversary of World Malaria Day, the IMVACS Consortium is extremely pleased to announce the launch of another significant and exciting research initiative in the fight against malaria: the CoSAV-R21 trial. In June 2025, Epicentre/MSF in collaboration with other IMVACS partners, the Liverpool School of Tropical Medicine (LSTM), and the Centre National de
- [Data Safety Monitoring Board Set up & organizational meeting](https://www.imvacs.org/data-safety-monitoring-board-set-up-organizational-meeting/) - The Data Safety Monitoring Board is officially in place! 📣The IMVACS team is glad to announce that its initial organizational Data Safety Monitoring Board meeting was successfully held on 31st March.
- [IMVACS Kick-off Meeting](https://www.imvacs.org/imvacs-kick-off-meeting/) - The project Kick-off Meeting was held in Abidjan, Côte d’Ivoire, on 11th and 12th February.
- [Stakeholders' Workshop for formative research in Mali](https://www.imvacs.org/stakeholders-workshop-for-formative-research-in-mali/) - Exciting update about IMVACS project As part of Work Package 6 on formative research, acceptability, feasibility, and cost-effectiveness, the IMVACS Consortium successfully convened a two-day stakeholders’ workshop on 7th and 8th March, in Dioïla, Mali.
- [IMVACS Clinical Trial Registration on PACTR](https://www.imvacs.org/imvacs-clinical-trial-registration-on-pactr/) - We’re delighted to announce that our clinical trial has officially been registered on the Pan African Clinical Trial Registry, marking a first crucial step towards reducing the malaria burden in sub-Saharan Africa!

## Pages

- [HOME PAGE](https://www.imvacs.org/) - Contact Us The 4-year IMVACS project, which runs from 1st December 2024 to 30th November 2028, is supported by the European and Developing Countries Clinical Trials Partnership (Global Health EDCTP3) and the European Union.
- [Events](https://www.imvacs.org/events/) - Events IMVACS Kick-off Meeting 11-12th February 2025 The project Kick-off Meeting was held in Abidjan, Côte d'Ivoire, on 11th and 12th February. To know more... Stakeholders' Workshop Mali 7-8th March 2025 In the context of formative research, a stakeholders' Workshop was organised in Dioïla, Mali, on 7th and 8th March. To know more... Stakeholders' Workshop
- [News](https://www.imvacs.org/news/) - News IMVACS Clinical Trial Registration on PACTR 05 February 2025 The IMVACS Clinical Trial has been successfully registered on the Pan African Clinical Trials Registry To know more... a new EVI clinical trial to protect pregnant women against malaria EVI has launched a Phase II clinical trial in Mali to evaluate the R21 malaria vaccine
- [IMVACS at MSF Scientific Day 2026](https://www.imvacs.org/imvacs-at-msf-scientific-day-2026/) - We’re proud to share that some partners from the IMVACS consortium will take part in the upcoming MSF Scientific Day on 20th May in London.An abstract submitted by the team has been accepted for an oral presentation, highlighting important research on:“Delivery R21 vaccine through seasonal malaria chemoprevention: coverage and qualitative insights from cluster-randomised trials in
- [IMVACS Annual Meeting Y2](https://www.imvacs.org/imvacs-annual-meeting-y2/) - The IMVACS Consortium convened its Year 2 Annual Meeting on 22nd- 23rd April 2026 at the Hilton Garden Inn in Lecce, Italy, in a hybrid format. The meeting was opened by Dr. Dario Scaramuzzi, IMVACS Project Coordinator, together with Prof. Alessandra Ferramosca from the local University of Salento, who welcomed participants and highlighted the importance
- [Stakeholders’ Workshop for formative research in Burkina Faso](https://www.imvacs.org/stakeholders-workshop-for-formative-research-in-burkina-faso/) - In continuity with the formative research initiative conducted the previous month in Mali, a similar stakeholders’ workshop was organised in Burkina Faso on 10th and 11th April 2025. The event was held at the Conference Hall of Hôtel Tantiga in Ziniaré and was attended by 85 participants, both in person and virtually. The primary objective
- [IMVACS at ASTMH 2025](https://www.imvacs.org/imvacs-at-astmh-2025/) - Some of our team proudly joined the ASTMH 2025 Annual Meeting from 9th to 13th November in Toronto, one of the most prestigious international gatherings in the field of tropical medicine, hygiene and global health.Professor Halidou Tinto (Centre National de la Recherche Scientifique et Technologique – Institut de Recherche en Sciences de la Santé, CNRST/IRSS)
- [Imvacs Consortium](https://www.imvacs.org/squadra/) - Prof. Natama Magloire (CNRST, Burkina Faso) Scientific Coordinator Find out more Dr. Valérie Briand (Epicentre, France) Sponsor of the Project Find out more Dr. Dario Scaramuzzi (R-EvoWW, Italy) Financial Coordinator Find out more Prof. Kassoum Kayentao (USTTB, Mali) Find out more Prof. Jenny Hill (LSTM, UK) Find out more Prof. Eve Worrall (LSTM, UK) Find
- [CoSAV-R21](https://www.imvacs.org/cosav-r21/) - Alongside the IMVACS project, members of the Consortium are also involved in another important initiative exploring innovative strategies for malaria prevention: the CoSAV-R21 trial. Launched in June 2025 by Epicentre/Médecins Sans Frontières (MSF) in collaboration with the Chadian Ministry of Public Health and Prevention, the Liverpool School of Tropical Medicine (LSTM), and the Centre National
- [IMVACS Project – First Round of Cross-Sectional Survey ](https://www.imvacs.org/imvacs-project-first-round-of-cross-sectional-survey/) - As part of the IMVACS project, two cross-sectional surveys are planned at the end of the peak malaria season (November 2025 and November 2026) in selected districts of Mali and Burkina Faso.The surveys assess vaccination coverage (EPI), SMC coverage, bednet use, and malaria parasitaemia prevalence in the community.The first survey was conducted in Mali (20th
- [Fieldworker training workshop on acceptability, feasibility, and cost-effectiveness in Mali and BF](https://www.imvacs.org/fieldworker-training-workshop-on-acceptability-feasibility-and-cost-effectiveness-in-mali-and-bf/) - From 10th to 14th November 2025, a fieldworker training workshop on acceptability, feasibility, and cost-effectiveness was held in Bamako, Mali, at the Department of Public Health, Point G.The training, led by Dr. Kadiatou Koita, Samba Diarra (qualitative components), and Dr. Hamidou Niangaly (quantitative components) from the University of Sciences, Techniques and Technologies of Bamako (USTTB),
- [World Children's Day - 20th November 2025](https://www.imvacs.org/world-childrens-day-20th-november-2025/) - Malaria remains a major health challenge for children in sub-Saharan Africa, with those under five being the most vulnerable. Through a novel integrated delivery strategy that combines the R21/Matrix-M malaria vaccine with Seasonal Malaria Chemoprevention (SMC) among children aged 5–36 months in areas of highly seasonal malaria transmission, the IMVACS project aims to reduce the
- [Prof. Halidou Tinto Visits Serum Institute of India to Advance Malaria Vaccine Collaboration ](https://www.imvacs.org/prof-halidou-tinto-visits-serum-institute-of-india-to-advance-malaria-vaccine-collaboration/) - From June 1st to 4th, 2025, Professor Halidou Tinto from the Centre National de la Recherche Scientifique et Technologique / Institut de Recherche en Sciences de la Santé (CNRST/IRSS) visited the Serum Institute of India (SII) in Pune, India.The visit marked an important step in the ongoing collaboration between IMVACS project partners and SII.The Serum
- [Official start of vaccination in Mali](https://www.imvacs.org/official-start-of-vaccination-in-mali/) - 10th June 2025 marked the official start of vaccination in the control arm of the IMVACS clinical trial in Dioïla district, Mali. Just two days earlier, on June 8th, a shipment of 9,000 doses of the R21/Matrix-M malaria vaccine had arrived in the district. By June 9th, the doses were distributed across the Dioïla's eight health
- [Official start of vaccination in Burkina Faso](https://www.imvacs.org/official-start-of-vaccination-in-burkina-faso/) - Following the successful launch in Mali, the IMVACS clinical trial has taken a significant step forward in Burkina Faso. On June 12th 2025, vaccination officially began in the control arm of the study in the Boussé district. This important step comes after several weeks of intensive preparation. From May 26th–28th 2025, Site Initiation Visits were
- [Update on SAFLI-R21-10: the IMVACS ancillary study](https://www.imvacs.org/update-on-safli-r21-10-the-imvacs-ancillary-study/) - SAFLI-R21-10 is an ancillary study conducted within the broader IMVACS project, operating under a stand-alone protocol independent of the main IMVACS study. The Principal Investigator for this ancillary study is Professor Kassoum Kayentao from the University of Sciences, Techniques and Technologies of Bamako (USTTB). The study aims to compare the safety, reactogenicity, and humoral immunogenicity
- [Echoes from the Field](https://www.imvacs.org/echoes-from-the-field/) - Echoes from the Field Chapter I 29th July 2025 Kola Cscom, Dioïla District, Mali To know more... Chapter II 8th August 2025 Boussé District, Burkina Faso To know more... Chapter III 1st October 2025 Dioïla District, Mali To know more... Chapter IV 24th October 2025 Dioïla District, Mali To know more...
- [Echoes from the Field - Chapter IV](https://www.imvacs.org/echoes-from-the-field-chapter-iv/) - 📅 24th October 2025📍 Dioïla District, Mali👥 Participants enrolled in the IMVACS study to date: 28,837It’s a wrap!For this year, the IMVACS team has successfully completed all four rounds of R-21 vaccine administration — in Mali from October 9th to 13th, and in Burkina Faso from October 16th to 19th.Next stop: the booster dose in
- [Echoes from the Field – Chapter III](https://www.imvacs.org/echoes-from-the-field-chapter-iii/) - 📅 1st October 2025📍 Dioïla District, Mali👥 Participants enrolled in the IMVACS study to date: 28,096Here in the Dioïla district, the third round of integrated SMC and R-21 vaccine administration wrapped up just few days ago, from September 11th to 14th.The team worked tirelessly to reach as many children as possible during those days. Now,
- [SAFLI-R21-10](https://www.imvacs.org/safli-r21-10/) - SAFLI-R21-10 SAFLI-R21-10 is an ancillary study conducted within the framework of the broader IMVACS project but under a stand-alone protocol separate from the main IMVACS study. This study is designed to compare the safety, reactogenicity, and humoral immunogenicity of the 10-dose (multidose) formulation of R-21/Matrix-M with 2-Phenoxyethanol (2-PE) preservative vs the safety, reactogenicity, and humoral
- [Echoes from the Field - Chapter II](https://www.imvacs.org/echoes-from-the-field-chapter-ii/) - 📅 8th August 2025📍 Boussé District, Burkina Faso👥 Participants enrolled in the IMVACS study to date: 23,774It’s been a few days since the first round of vaccinations in the intervention arm of the IMVACS project here in Burkina Faso...and what a week it was!From the 24th to the 27th of July, the dusty village paths
- [Echoes from the Field - Chapter I](https://www.imvacs.org/echoes-from-the-field-chapter-i/) - 📅 29th July 2025📍 Kola Cscom, Dioïla District, Mali👥 Participants enrolled in the IMVACS study to date: 23,227Today, as every Tuesday, is vaccination day at the Kola Centre de Santé Communautaire.In the control arm of the IMVACS clinical trial in Mali, the fixed-site vaccination strategy means that caregivers bring their children to the health facility
- [TSC Set up](https://www.imvacs.org/tsc-set-up/) - The IMVACS Consortium has assembled a Trial Steering Committee (TSC) to provide critical oversight for the planning, implementation, and monitoring of the study. TSC plays a central role in ensuring that the trial adheres to Good Clinical Practice and relevant regulatory standards, while addressing any emerging scientific, operational, or health-related issues that could impact the
- [Data Safety Monitoring Board Set up & organizational meeting](https://www.imvacs.org/data-safety-monitoring-board-set-up-organizational-meeting/) - On 31st March 2025, IMVACS Consortium held its initial organizational meeting with the newly appointed Data Safety and Monitoring Board (DSMB) members. DSMB members: Dr. Raquel Gonzales - Medical Researcher, Epidemiologist from the Universitat de Barcelona/ Barcelona Institute for Global Health (ISGlobal) Dr. Patricia Fassinou - Pediatrician, Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) Dr. Sanni
- [Stakeholders' Workshop for formative research in Mali](https://www.imvacs.org/stakeholders-workshop-for-formative-research-in-mali/) - As part of Work Package 6 (WP6) about formative research, acceptability, feasibility, and cost-effectiveness, the IMVACS Consortium organised a stakeholders’ workshop on 7th and 8th March 2025. The main objective of the meeting was to provide comprehensive information about the study and to collaboratively co-design intervention implementation strategies that are tailored to the specific context
- [IMVACS Clinical Trial Registration on PACTR](https://www.imvacs.org/imvacs-clinical-trial-registration-on-pactr/) - The IMVACS Consortium has officially registered its Clinical trial on the Pan African Clinical Trial Registry. This marks the first successful step towards reducing the malaria burden in sub-Saharan Africa!
- [IMVACS Kick-off meeting](https://www.imvacs.org/imvacs-kick-off-meeting/) - On 11th and 12th February 2025, the IMVACS Consortium held its Kick-off Meeting at Novotel Marcory, in Abidjan, Côte d'Ivoire. The meeting was opened by Prof. William Yavo, the General Director of the National Institute of Public Health (INSP) of Côte d’Ivoire who was pleased to host the IMVACS team in Abidjan. All the European
- [Newsletter](https://www.imvacs.org/newsletter-2/)
- [IMVACS PROJECT](https://www.imvacs.org/informazioni/) - A NEW FRONTIER FOR PUBLIC HEALTH IN AFRICA Challenge In the past two decades, significant progress has been made in the fight against malaria and the global burden of malaria has declined significantly. However, malaria remains a major health problem with huge socio-economic impact, on individual, family, community, and national levels in sub-Saharan Africa. In
- [Contact Us](https://www.imvacs.org/contact-us/)
- [Manage Subscriptions](https://www.imvacs.org/manage-subscriptions/) - [newsletters_management]
- [Servizi](https://www.imvacs.org/servizi/) - Soluzioni integrate per la salute, prevenzione e vaccini Esplora le nostre soluzioni innovative per la prevenzione della malaria in Africa occidentale. Soluzioni per il benessere e la prevenzione Scopri i nostri servizi dedicati alla salute e alla prevenzione della malaria. Dalla vaccinazione alla consulenza, siamo qui per te. Prenota oggi stesso! Vaccinazioni Preventive Vaccinazioni di
- [Galleria](https://www.imvacs.org/galleria/) - Esplora il progetto IMVACS Scopri i dettagli del progetto IMVACS per integrare il vaccino antimalarico. Visita la nostra collezione Esamina i nostri progetti e risultati Risultati del Progetto Scopri come il progetto IMVACS sta impattando la lotta contro la malaria in Africa. Dati scientifici che supportano decisioni sanitarie efficaci. Maria Rossi Esperta di sanità pubblica
- [Newsletter](https://www.imvacs.org/contatto/) - Do you have questions about imvacs project? FIND OUT more about IMVACS Project Contact us Esplora il progetto IMVACS per la salute pubblica Unisciti a noi per scoprire come IMVACS integra il vaccino antimalarico con la chemoprevenzione per un futuro più sano in Africa occidentale. Ulteriori dettagli Approfondisci ora
- [Newsletter](https://www.imvacs.org/newsletter/)
- [Sample Page](https://www.imvacs.org/sample-page/) - This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I'm a bike messenger

## Categories

- [Uncategorized](https://www.imvacs.org/category/uncategorized/)
- [News](https://www.imvacs.org/category/news/)